Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor Y13157

Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor Y13157 Descriptor: 2-(2-cyclobutyl-1~{H}-imidazol-5-yl)-7-[2-(4-fluoranyl-2,6-dimethyl-phenoxy)-5-(2-oxidanylpropan-2-yl)phenyl]-5-methyl-furo[3,2-c]pyridin-4-one, Bromodomain-containing protein 4, GLYCEROL Authors: Li, J, Zhang, C, Xu, H, Zhuang, X, Wu, X, Zhang, Y, Xu, Y. Deposit date: 2022-01-07 Release date: 2022-08-10 Last modified: 2023-11-29 Method: X-RAY DIFFRACTION (2.73 Å) Cite: Structure-Based Discovery and Optimization of Furo[3,2- c ]pyridin-4(5 H )-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) Inhibitors. J.Med.Chem., 65, 2022

人类BRD4首个溴结构域（bromodomain）与抑制剂Y13157复合物的晶体结构
描述信息：2-(2-环丁基-1H-咪唑-5-基)-7-[2-(4-氟-2,6-二甲基苯氧基)-5-(2-羟基丙-2-基)苯基]-5-甲基呋喃并[3,2-c]吡啶-4-酮、溴结构域包含蛋白4（Bromodomain-containing protein 4）、甘油（GLYCEROL）
作者：Li, J、Zhang, C、Xu, H、Zhuang, X、Wu, X、Zhang, Y、Xu, Y
提交日期：2022-01-07
发布日期：2022-08-10
最后修改日期：2023-11-29
实验方法：X射线衍射（X-RAY DIFFRACTION），分辨率2.73埃
引用文献：《基于结构的呋喃并[3,2-c]吡啶-4(5H)-酮衍生物的发现与优化：强效且选择性靶向第二个溴结构域（BD2）的BET（Bromo and Extra Terminal Domain）抑制剂》，《药物化学杂志（J.Med.Chem.）》，2022年，第65卷